Lung Cancers Withdrawn Phase 1 / 2 Trials for Bevacizumab (DB00112)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00411593Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)Treatment